Clinical Trial Update: Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pacritinib in metastatic castration-resistant prostate cancer that progressed after prior androgen receptor signaling inhibito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING